CWM
MRNA icon

Crowley Wealth Management’s Moderna MRNA Stock Holding History

Crowley Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-700
Closed -$18.1K – 221
2025
Q3 		$18.1K Hold
700
– – 0.01% 232
2025
Q2 		$19.3K Hold
700
– – 0.02% 213
2025
Q1 		$19.8K Sell
700
-275
-28% -$9.76K 0.02% 201
2024
Q4 		$40.5K Buy
+975
New +$46.6K 0.04% 153

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Crowley Wealth Management's MRNA Position: Q4 2025 in Review

Crowley Wealth Management sold out of Moderna (MRNA) in Q4 2025, closing a stake of 700 shares — an estimated $18.1K sold.

Crowley Wealth Management first reported a position in MRNA in Q4 2024 and held it in 4 quarters. The position peaked at $40.5K in Q4 2024. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Crowley Wealth Management reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Crowley Wealth Management sold 700 Moderna shares in Q4 2025, an estimated $18.1K.
  • Crowley Wealth Management first reported a position in Moderna in Q4 2024 and held it in 4 quarters.
  • Crowley Wealth Management's Moderna position peaked at $40.5K in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Crowley Wealth Management's 13F filing for Q4 2025.